Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

AIM: To compare effectiveness of dapagliflozin versus DPP-4 inhibitors on individualized HbA1c targets and extra-glycaemic endpoints among elderly patients with type 2 diabetes (T2D). METHODS: This was a multicentre retrospective study on patients aged 70–80 years with HbA1c above individualized tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, M. L., Raz, I., Consoli, A., Rigato, M., Lapolla, A., Broglio, F., Bonora, E., Avogaro, A., Fadini, G. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261249/
https://www.ncbi.nlm.nih.gov/pubmed/36624223
http://dx.doi.org/10.1007/s40618-022-02002-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261249/
https://www.ncbi.nlm.nih.gov/pubmed/36624223
http://dx.doi.org/10.1007/s40618-022-02002-2

Ejemplares similares